Browsing Tag

Partnering

580 posts

Global Pharma Briefs: News from the US
By

By
A roundup of news from the US (AbbVie, Colorcon Ventures, BioMarin Pharmaceutical, and Bayshore Pharmaceuticals). AbbVie, Harvard Form $30-M Research Pact for Emergent Viral DiseasesAbbVie and Harvard University have entered…

CureVac, EU Conclude Talks for Supply of COVID-19 Vaccine Candidate
By

By
CureVac, a Tubingen, Germany-based clinical-stage biopharmaceutical company developing a messenger ribonucleic acid (mRNA) therapeutics, and the European Commission (EC) have concluded exploratory talks outlining an advanced purchase agreement to supply…

Pharma COVID Roundup: News from J&J, Novavax, Roche, and Regeneron
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from J&J, Novavax, Roche, Regeneron, BI, Dr. Reddy’s, CSL, and others. J&J in Supply Pact with UK Gov’t for…

Global Pharma Briefs: News from Asia, Europe, and the US
By

By
A roundup of news from Denmark (Novo Nordisk), Germany (Evotec, Novo Nordisk), Japan (Takeda), and the US (Lupin, Sun Pharma, Alnylam, Teva, and others). Denmark Novo Nordisk To Invest $135…

Lilly, Innovent Biologics Expand Immuno-Oncology Pact in $1-Bn Deal
By

By
Eli Lilly and Company and Innovent Biologics, a Suzhou, China-based biopharmaceutical company, have announced a global expansion of their strategic alliance for TYVYT (sintilimab), an anti-PD-1 monoclonal antibody immuno-oncology medicine,…

Gilead Sciences, Tango Therapeutics in $6.3-Bn Cancer-Drug Pact
By

By
Gilead Sciences and Tango Therapeutics, a Cambridge, Massachusetts-based company developing cancer therapies, have expanded their strategic collaboration to discover, develop, and commercialize targeted immune-evasion therapies for cancer in a deal…

BMS, Dragonfly Therapeutics in $475-M Pact for Immunotherapy
By

By
Bristol Myers Squibb (BMS) and Dragonfly Therapeutics, a Waltham, Massachusetts-based company specializing in cancer immunotherapies, have formed a collaboration, worth up to $475 million, for Dragonfly’s immunotherapy candidate, DF6002, for…

AstraZeneca Closes Supply Pact with EC for 400 M Doses of COVID Vaccine
By

By
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of AZD1222, the COVID-19 vaccine co-invented by the University of Oxford and its…

Pharma COVID Roundup: News from Pfizer, Gilead, AstraZeneca, Takeda
By

By
The latest on manufacturing and potential treatments for COVID-19 with news from Pfizer, Gilead Sciences, AstraZeneca, Takeda, Novavax, Daiichi Sankyo, and others. Pfizer in Pact to Manufacture Gilead’s Remdesivir for…

Moderna Gets $1.5-Bn US Gov’t Contract for Supply of its COVID Vaccine
By

By
Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has been awarded up to $1.525 billion, including incentive payments, by the US government to manufacture and deliver…